Liezel L. Griffin, M., Laura Cove-Smith, P., Hana Alachkar, M., John A. Radford, M., Rebecca Brooke, M., & Kim M. Linton, P. (2018). Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma. Elsevier.
Chicago Style (17th ed.) CitationLiezel L. Griffin, MBBS, PhD Laura Cove-Smith, MD Hana Alachkar, MD John A. Radford, MD Rebecca Brooke, and PhD Kim M. Linton. Toxic Epidermal Necrolysis (TEN) Associated with the Use of Nivolumab (PD-1 Inhibitor) for Lymphoma. Elsevier, 2018.
MLA (9th ed.) CitationLiezel L. Griffin, MBBS, et al. Toxic Epidermal Necrolysis (TEN) Associated with the Use of Nivolumab (PD-1 Inhibitor) for Lymphoma. Elsevier, 2018.
Warning: These citations may not always be 100% accurate.